Menu Search Icon

Search

Division of Infectious Diseases & International Health

The UVA Division of Infectious Diseases & International Health has a long tradition of excellence in research, patient care and education. Division faculty are extending the tradition into new frontiers of research, and training a new generation of physician-scientists to meet the challenges of infectious diseases in an increasingly “flat” global community.

Research is supported by more than $29 million in annual extramural funding in 8 departments and 4 divisions in the School of Medicine, including global health initiatives supported by the Bill & Melinda Gates Foundation and the NIH, and carried out with partners in countries around the world, among them Bangladesh, Brazil, Haiti, South Africa, Tanzania and Uganda.

DEPARTMENT OF MEDICINE

Infectious Disease Fellowship Training Program

The University of Virginia's Division of Infectious Disease Fellowship Training Program program offers rigorous training and supervised experience with faculty members who have broad clinical and research expertise. Watch our video to learn more.

Fellowship Applications

The goal the division’s training programs is to prepare students and fellows as independent investigators in the field of infectious diseases. Our philosophy is that interactions between basic scientists and clinicians in research and during training are essential for the breakthroughs and discoveries needed in this field.

To Apply
Dr. Bill Petri

Melissa Kendall, PhD, and Bill Petri, MD, PhD, Discuss E. Coli in Your Food

To better understand E. coli and its impact on human health, UVA Today reached out to Melissa Kendall, PhD, an associate professor in the Department of Microbiology, Immunology and Cancer Biology, and William Petri, MD, PhD, the Wade Hampton Frost Professor of Medicine, to get their insights into the outbreak.

Read More

Dr. Patrick Jackson

Dr. Patrick Jackson talks with Reuters about a new HIV medication.

“When lenacapavir is used for treatment in people living with HIV, it has to be given in combination with other drugs. If a person stops taking treatment, the virus will return. Lenacapavir is also not a vaccine. If a person using lenacapavir for PrEP stops getting doses, they can be at risk for acquiring HIV.” Jackson said

Read More

Scott Heysell, MD discusses his work in treating the infections of poverty like tuberculosis.

"Our work impacts human health for Virginians and for communities globally, such as those with whom we deeply collaborate in Tanzania, Uganda, and Bangladesh.

Watch Video

Research in Motion - Eric Houpt, MD

“The main focus of my research is to develop molecular tools, think of it like a magnifying glass, that can really finely diagnose the cause of different infections. We apply this to lung diseases, childhood infections, and diarrheal diseases.” —Eric Houpt, MD

 

"Dr Amy Mather's efforts have been absolutely critical in allowing us to address and understand this pandemic.." ~ Mitchell H. Rosner, MD MACP, Chair, Department of Medicine

Doctors at the University of Virginia Medical Center wanted to test patients who may be infected by the novel coronavirus. First, they had to overcome obstacles that set them back weeks

Read More

Center for Global Health Equity (CGHE)

CGHE works to support the development of global health leaders and global health capacity with partner institutions, organizations, faculty and students

Learn More

News All News »

Message From the Chair’s Office – May 2025

Dear Friends and Colleagues, We find ourselves in a time of real challenge in academic medicine. Across the country, departments like ours are navigating financial pressures, workforce constraints, and a…

Division of Asthma, Allergy and Immunology Research and Educational Update – May 2025

I am so proud of our faculty and staff’s resilience and commitment to our mission. As the mighty challenges mount, they grow stronger and closer together as a team. Whether…

Division of Hematology and Oncology Research and Educational Update – April 2025

Message from Dr. Karen Ballen, Division Chief of Hematology and Oncology It is an honor to highlight the successes of our incredible Hematology/Oncology Division. We have had another excellent year…

Message from the Acting Chair

Dear Friends and Colleagues, It’s been a little over a month since I started my role as acting chair for the Department of Medicine, and this newsletter is the first…

Division of Pulmonary and Critical Care Research and Educational Updates – March 2025

Message from Dr. Imre Noth, Division Chief of Pulmonary and Critical Care I am so happy to share our continued growth this past year and moving forward. Exciting things are…